KNSA
Kiniksa Pharmaceuticals Ltd.
$37.24
-$0.65(-1.72%)
66
Overall
40
Value
83
Tech
76
Quality
Market Cap
$2.81B
Volume
192.87K
52W Range
$17.82 - $39.43
Target Price
$47.13
EPS Estimates Overview
| Current Quarter | $0.31 | Next Quarter | $0.41 |
| Current Year | $1.03 | Next Year | $1.6 |
| QoQ Growth | +32.3% | YoY Growth | +55.3% |
| 3Y EPS CAGR | +36.1% | Target Price | $47.13 |
| Consensus | Buy | Upside | +26.6% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KNSA | $37.24 | -1.7% | 192.87K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kiniksa Pharmaceuticals Ltd. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW